Scintigraphy with 57Co‐bleomycin in the detection of lung cancer: A review of 268 well‐documented patients

Over a 5‐year period 57Co‐bleomycin scintigraphy for tumor detection was performed with a large‐field‐of‐view gamma camera. The scintigrams of 268 patients with lung cancer, with a benign lesion, or with no abnormality in the chest, were reviewed. A sensitivity of 96% was found. In a group of 193 patients in whom a preoperative pathologic diagnosis could not be obtained sensitivity was 95%, specificity was 87%. Correlation between tumor size and tumor‐to‐non‐tumor ratio was established for squamous cell carcinoma, adenocarcinoma, and small cell anaplastic carcinoma. Adenocarcinomas were smaller and showed lower tumor‐to‐non‐tumor ratios than other histologic types. In squamous cell carcinoma a possible correlation between tumor‐to‐non‐tumor ratio and histologic differentiation was investigated, but could not be established. It is concluded that 57Co‐bleomycin scintigraphy is helpful in the evaluation of patients with possible lung cancer in whom a preoperative pathologic diagnosis cannot be obtained.

[1]  J. Rasker,et al.  Some experience with 57Co-labeled bleomycin as a tumor-seeking agent. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  R. Reba,et al.  Cobalt-labeled bleomycin--a new radiopharmaceutical for tumor localization. A comparative clinical evaluation with gallium citrate. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  J. Rasker,et al.  Cobalt-57-bleomycin scanning of hila and mediastinum in patients with bronchial carcinoma: a prospective study. , 1976, Thorax.

[4]  K. Hisada,et al.  [Clinical evaluation of tumor scanning with 57Co bleomycin]. , 1974, Kaku igaku. The Japanese journal of nuclear medicine.

[5]  S. Ekholm,et al.  Computed Tomography in Preoperative Staging of Bronchogenic Carcinoma , 1980, Journal of computer assisted tomography.

[6]  D. Sartoris,et al.  Clinical studies with In-111 BLEDTA, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  L. Mamo,et al.  Use of radioactive bleomycin to detect malignant intracranial tumors. Comparative study with technetium-99m in 104 cases. , 1973, Journal of neurosurgery.

[8]  R. Reba,et al.  Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection. , 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  M. Kojima,et al.  Tumor scanning with 57Co-Bleomycin , 1972 .

[10]  J. Husband,et al.  Computed tomography of the body: when should it be used? , 1982, British medical journal.